Coldstream Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $616K | Buy |
2,145
+43
| +2% | +$12.4K | 0.01% | 572 |
|
|
2025
Q1 | $648K | Sell |
2,102
-77
| -4% | -$23.7K | 0.01% | 499 |
|
|
2024
Q4 | $769K | Buy |
2,179
+13
| +0.6% | +$4.59K | 0.02% | 438 |
|
|
2024
Q3 | $779K | Buy |
2,166
+79
| +4% | +$28.4K | 0.02% | 453 |
|
|
2024
Q2 | $665K | Buy |
2,087
+81
| +4% | +$25.8K | 0.02% | 444 |
|
|
2024
Q1 | $461K | Sell |
2,006
-39
| -2% | -$8.96K | 0.01% | 586 |
|
|
2023
Q4 | $450K | Sell |
2,045
-82
| -4% | -$18K | 0.01% | 552 |
|
|
2023
Q3 | $480K | Buy |
2,127
+33
| +2% | +$7.45K | 0.02% | 442 |
|
|
2023
Q2 | $462K | Buy |
2,094
+86
| +4% | +$19K | 0.01% | 475 |
|
|
2023
Q1 | $450K | Sell |
2,008
-15
| -0.7% | -$3.36K | 0.02% | 471 |
|
|
2022
Q4 | $563K | Buy |
+2,023
| New | +$563K | 0.02% | 397 |
|
|
2022
Q2 | $468K | Buy |
1,989
+215
| +12% | +$50.6K | 0.02% | 413 |
|
|
2022
Q1 | $318K | Sell |
1,774
-49
| -3% | -$8.78K | 0.01% | 548 |
|
|
2021
Q4 | $394K | Buy |
+1,823
| New | +$394K | 0.01% | 510 |
|